|Post IPO Valuation|
|Description||American Healthcare Company|
|Chatham Therapeutics, 4/2014||$70M|
|Prism Pharmaceuticals, 4/2011||$338M|
Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions.
The company operates through three segments: BioScience, Medication Delivery, and Renal.
Baxter International Inc. has collaborations with HHD LLC, DEKA Products Limited Partnership, and DEKA Research and Development Corp. for the development of a home hemodialysis machine. It markets its products to hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors offices, clinical and medical research laboratories, and patients at home under physician supervision.
The company was founded in 1931 and is headquartered in Deerfield, Illinois.